Clinical Trials | October 03, 2023
Zydus announces IND clearance of a novel Anti-PCSK9 candidate
Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity
Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity
Dr. Karikó is the third Solvay Prize winner to become a Nobel Prize laureate
The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types
‘Sanjeevani’ aims to raise awareness and encourage conversations around the silent cancer epidemic
India is promoting holistic healthcare with emphasis on preventive care
Dr. Jitendra Singh inaugurates 300 LPM capacity Oxygen Plant, Day Care Chemotherapy Unit affiliated to Tata Memorial Hospital & Maternal ICU at GMC Kathua
The partnership is part of BioNTech’s strategy to develop novel prophylactic vaccines for the prevention of high-medical-need infectious diseases
CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
The Government of India continues to prioritise initiatives aimed at enhancing the accessibility and equity of health services
,_HQ_and_T7_RNA_polymerase,_HQ__From_left_to_right_256_384.jpg)
Subscribe To Our Newsletter & Stay Updated
